INCY

NASD Incyte Corporation
Oct 7, 2026 · 5:31 AM ET LAST TRADE Market Closed

$112.77 ↑ +0.04 (+0.04%) Trading Up from the previous close of $112.73

YTD change
+14.17%
vs 20-day SMA
-7.78%
vs 200-day SMA
+5.38%

Price ranges

Previous day
$111.67 $114.97
open $114.13 close $112.73
-$1.40 (-1.23%)
Today
$0.00 $0.00
$112.77
Past week
$111.67 $124.23
from $123.20 now $112.77
-$10.43 (-8.47%)
Past month
$111.67 $128.72
from $124.40 now $112.77
-$11.63 (-9.35%)
This year
$89.25 $132.60
from $98.77 now $112.77
+$14.00 (+14.17%)

Price & Performance

+19.04 (+20.32%) / 6M

$89.22$103.80$118.37$132.95Apr 7Jul 8Oct 6

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 26.4% away from all-time highs of $153.15
  • INCY is up 14% since the beginning of the year
  • INCY is up 29% over the past 12 months
  • INCY is down 9% over the past 1 month
  • 5% of all INCY investors are betting against INCY

INCY reads not so good: price sits above one of the two key moving averages, the 12-month move is +29.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $3.09
Earnings momentum +196.3% Quarterly EPS growth
Quarterly change +196.3%

Valuation

P/E ratio 14.69
Enterprise value $19.3B
Beta 0.76

Balance sheet & scale

Income$1.6M
Revenue$5.8B
Cash$4.5B
Debt$38.3K
Income / Debt 42.13×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $22.9B

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and autoimmunity therapeutic areas. The company was founded on April 8, 1991 and is headquartered in Wilmington, DE.

Competitor comparison

TickerCompany PriceChange
CMXHF CSL Limited $127.68 +0.14%
ARGX argenx SE Sponsored ADR $930.52 +1.93%
ONC BeOne Medicines Ltd. Sponsored ADR $362.78 +0.31%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $14.79 +3.43%
IVBXF Innovent Biologics, Inc. $12.20 -4.70%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.